Antibiotic pharmacokinetics in infected pleural effusions
- PMID: 38964858
- PMCID: PMC11347206
- DOI: 10.1136/thorax-2023-220402
Antibiotic pharmacokinetics in infected pleural effusions
Abstract
Pleural infection is usually treated with empirical broad-spectrum antibiotics, but limited data exist on their penetrance into the infected pleural space. We performed a pharmacokinetic study analysing the concentration of five intravenous antibiotics across 146 separate time points in 35 patients (amoxicillin, metronidazole, piperacillin-tazobactam, clindamycin and cotrimoxazole). All antibiotics tested, apart from co-trimoxazole, reach pleural fluid levels equivalent to levels within the blood and well above the relevant minimum inhibitory concentrations. The results demonstrate that concerns about the penetration of commonly used antibiotics, apart from co-trimoxazole, into the infected pleural space are unfounded.
Keywords: Bacterial Infection; Pleural Disease; Pneumonia; Respiratory Infection.
© Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY. Published by BMJ.
Conflict of interest statement
Competing interests: None declared.
Figures
References
-
- Bhatnagar R, Skouras V, Rahman N, et al. . Antibiotics for pleural infections. Eur Respir Monogr 2017;75:253–63. 10.1183/2312508X.erm7517 - DOI
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical